This inventor holds 12 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Regents of the University of Minnesota, University of Kansas, Mayo Foundation for Medical Education and Research. Active years: 2000-2025.
Location History:
- Lawrence, KS (US) (2000 - 2009)
- Minneapolis, MN (US) (2019 - 2020)
- Saint Paul, MN (US) (2017 - 2022)
Company Filing History:
7 out of 2,367 
7 out of 571 
3 out of 1,805 
Years Active: 2000-2025
Title: Gunda I Georg: Innovator in Therapeutic Compounds
Introduction
Gunda I Georg is a prominent inventor based in Saint Paul, MN (US), known for her significant contributions to the field of therapeutic compounds. With a total of 12 patents to her name, she has made remarkable strides in developing innovative solutions for various medical conditions.
Latest Patents
Among her latest patents, Gunda I Georg has developed therapeutic compounds and methods of use thereof. This invention provides a compound of formula (I) or a salt thereof, wherein A, B, R, R, R, and X have any of the values described in the specification. The compounds are particularly useful as therapeutic agents for treating diastolic dysfunction. Additionally, she has created therapeutics for the treatment of glaucoma. This invention includes benzothiadiazine and chroman derivatives, specifically diazoxide and cromakalim derivatives, which are used to treat glaucoma, retinopathy, and age-related macular degeneration. These compounds help stabilize and inhibit blood and lymph vascularization while reducing intraocular pressure by administering a pharmaceutically effective amount of a prodrug in an ophthalmically acceptable carrier.
Career Highlights
Gunda I Georg has had a distinguished career, working with reputable institutions such as the University of Kansas and the Regents of the University of Minnesota. Her work has significantly impacted the field of therapeutic development, showcasing her expertise and dedication to advancing medical science.
Collaborations
Throughout her career, Gunda has collaborated with notable professionals, including Michael P Fautsch and Sajiv K Nair. These collaborations have further enriched her research and contributed to her innovative work in therapeutics.
Conclusion
Gunda I Georg stands out as a leading inventor in the realm of therapeutic compounds, with a focus on addressing critical health issues. Her contributions continue to influence the medical field, making her a significant figure in innovation and invention.